Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Ravanelli

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
World Neurosurgery|November 16, 2019
Quantitative Anatomical Comparison of Anterior, Anterolateral and Lateral, Microsurgical and Endoscopic Approaches to the Middle Cranial FossaGiorgio Saraceno, Edoardo Agosti, Jimmy Qiu, et al.
Acta Neurochirurgica|December 4, 2019
Quantitative anatomical comparison of transnasal and transcranial approaches to the clivusEdoardo Agosti, Giorgio Saraceno, Jimmy Qiu, et al.
Breast Cancer Research and Treatment|January 20, 2026
Fracture risk in metastatic breast cancer patients treated with CDK 4/6 inhibitors and endocrine therapyRebecca Pedersini, Laura Moretti, Marta Laganà, et al.
Breast (Edinburgh, Scotland)|September 12, 2024
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter?Rebecca Pedersini, Greta Schivardi, Marta Laganà, et al.
Oral Oncology|August 11, 2023
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinomaElisabetta Roberti, Marco Merlano, Marco Ravanelli, et al.
European Journal of Cancer (Oxford, England : 1990)|May 10, 2023
The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumoursCarlo Resteghini, Paolo Castelnuovo, Piero Nicolai, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2025
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trialPaolo Bossi, Andrea Alberti, Cristiana Bergamini, et al.
Oral Oncology|February 14, 2022
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinomaDavide Lombardi, Michele Tomasoni, Luigi Lorini, et al.
European Urology|May 21, 2024
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving EnzalutamideAlberto Dalla Volta, Francesca Valcamonico, Andrea Zivi, et al.
Prostate Cancer and Prostatic Diseases|May 3, 2025
Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trialAlberto Dalla Volta, Francesca Valcamonico, Andrea Zivi, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
World Neurosurgery|November 16, 2019
Quantitative Anatomical Comparison of Anterior, Anterolateral and Lateral, Microsurgical and Endoscopic Approaches to the Middle Cranial FossaGiorgio Saraceno, Edoardo Agosti, Jimmy Qiu, et al.
Acta Neurochirurgica|December 4, 2019
Quantitative anatomical comparison of transnasal and transcranial approaches to the clivusEdoardo Agosti, Giorgio Saraceno, Jimmy Qiu, et al.
Breast Cancer Research and Treatment|January 20, 2026
Fracture risk in metastatic breast cancer patients treated with CDK 4/6 inhibitors and endocrine therapyRebecca Pedersini, Laura Moretti, Marta Laganà, et al.
Breast (Edinburgh, Scotland)|September 12, 2024
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter?Rebecca Pedersini, Greta Schivardi, Marta Laganà, et al.
Oral Oncology|August 11, 2023
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinomaElisabetta Roberti, Marco Merlano, Marco Ravanelli, et al.
European Journal of Cancer (Oxford, England : 1990)|May 10, 2023
The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumoursCarlo Resteghini, Paolo Castelnuovo, Piero Nicolai, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2025
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trialPaolo Bossi, Andrea Alberti, Cristiana Bergamini, et al.
Oral Oncology|February 14, 2022
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinomaDavide Lombardi, Michele Tomasoni, Luigi Lorini, et al.
European Urology|May 21, 2024
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving EnzalutamideAlberto Dalla Volta, Francesca Valcamonico, Andrea Zivi, et al.
Prostate Cancer and Prostatic Diseases|May 3, 2025
Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trialAlberto Dalla Volta, Francesca Valcamonico, Andrea Zivi, et al.
Pageof 13